ESC 2021 | GREENNESS: Surprising New Protective Factor against Cardiovascular Disease

What Is “Greenness”? This factor—which generally refers to the proximity to vegetation, as measured by satellite pictures—could serve as a new protection against cardiovascular disease.

During five years (the total research time), this study compared individuals who lived in the lowest tercile of “greenness” with those who lived in the highest tercile (i.e., those who lived closer to nature).

Living in open spaces decreased the probability of acute myocardial infarction, atrial fibrillation, heart failure, ischemic heart disease, hypertension, or stroke by 16% (p < 0.001).

Those who lived in greener areas but still suffered from cardiovascular disease had a protective factor, presenting far fewer subsequent events than their urban peers.

During the study period, the City of Miami promoted a very ambitious program for planting trees and developing green spaces.

This allowed many people initially classified in the lowest tercile in 2011 to move to the middle or even the highest tercile by 2016.

These changes resulted in a 15-% decrease in new diagnoses of cardiovascular disease compared with subjects who remained in the lowest tercile (p < 0.001).

Although this association seems quite evident, how green spaces directly impact the development of cardiovascular disease is still unclear. While obvious data such as air quality, water, lifestyle, diet, classic risk factors, exercise, stress, or access to healthcare centers were adjusted for, others, such as socioeconomic factors, could not be taken into account.


Read also: ESC 2021 | Empagliflozin in Heart Failure with Reduced and Preserved Ejection Fraction.


The concept could be incorporated into patient education on healthy eating and regular exercise—ideally in nature, if possible.

If areas with sufficient nature or any type of open space do not exist in the neighborhood, the issue should be raised as a health concern before politicians, so that all people have equal access to these types of environments.

Original Title: Longitudinal impact of greenness on cardiovascular disease conditions.

Reference. Aitken W, presentado durante el congreso de la ESC en agosto 2021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...